Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0000320017-26-000038
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $70.00K | $0.00 | $0.00 |
| Net Income | -$2.93M | -$4.66M | -$5.04M | -$4.03M |
| EPS Diluted | -$0.32 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.54 |
| -$0.61 |
| -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
